259 related articles for article (PubMed ID: 23668298)
1. β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.
Jenkins RE; Yaseen FS; Monshi MM; Whitaker P; Meng X; Farrell J; Hamlett J; Sanderson JP; El-Ghaiesh S; Peckham D; Pirmohamed M; Park BK; Naisbitt DJ
Chem Res Toxicol; 2013 Jun; 26(6):963-75. PubMed ID: 23668298
[TBL] [Abstract][Full Text] [Related]
2. Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients.
Meng X; Al-Attar Z; Yaseen FS; Jenkins R; Earnshaw C; Whitaker P; Peckham D; French NS; Naisbitt DJ; Park BK
J Immunol; 2017 Jun; 198(11):4217-4227. PubMed ID: 28438900
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.
El-Ghaiesh S; Monshi MM; Whitaker P; Jenkins R; Meng X; Farrell J; Elsheikh A; Peckham D; French N; Pirmohamed M; Park BK; Naisbitt DJ
J Pharmacol Exp Ther; 2012 Jun; 341(3):597-610. PubMed ID: 22371438
[TBL] [Abstract][Full Text] [Related]
4. Nonimmediate β-lactam reactions in patients with cystic fibrosis.
Whitaker P; Naisbitt D; Peckham D
Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):369-75. PubMed ID: 22729028
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals.
Brander C; Mauri-Hellweg D; Bettens F; Rolli H; Goldman M; Pichler WJ
J Immunol; 1995 Sep; 155(5):2670-8. PubMed ID: 7650395
[TBL] [Abstract][Full Text] [Related]
6. Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis.
Moss RB
J Allergy Clin Immunol; 1991 Jan; 87(1 Pt 1):78-88. PubMed ID: 1991925
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.
Whitaker P; Meng X; Lavergne SN; El-Ghaiesh S; Monshi M; Earnshaw C; Peckham D; Gooi J; Conway S; Pirmohamed M; Jenkins RE; Naisbitt DJ; Park BK
J Immunol; 2011 Jul; 187(1):200-11. PubMed ID: 21606251
[TBL] [Abstract][Full Text] [Related]
8. Successful meropenem desensitization in a patient with cystic fibrosis.
Wilson DL; Owens RC; Zuckerman JB
Ann Pharmacother; 2003 Oct; 37(10):1424-8. PubMed ID: 14519038
[TBL] [Abstract][Full Text] [Related]
9. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity.
Lochmatter P; Beeler A; Kawabata TT; Gerber BO; Pichler WJ
Allergy; 2009 Sep; 64(9):1269-78. PubMed ID: 19254289
[TBL] [Abstract][Full Text] [Related]
10. Detection of drug-responsive B lymphocytes and antidrug IgG in patients with β-lactam hypersensitivity.
Amali MO; Sullivan A; Jenkins RE; Farrell J; Meng X; Faulkner L; Whitaker P; Peckham D; Park BK; Naisbitt DJ
Allergy; 2017 Jun; 72(6):896-907. PubMed ID: 27861994
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactam allergy in adults with cystic fibrosis.
Burrows JA; Nissen LM; Kirkpatrick CM; Bell SC
J Cyst Fibros; 2007 Jul; 6(4):297-303. PubMed ID: 17182289
[TBL] [Abstract][Full Text] [Related]
12. Allergic reactions to beta-lactams.
Rodriguez-Pena R; Antunez C; Martin E; Blanca-Lopez N; Mayorga C; Torres MJ
Expert Opin Drug Saf; 2006 Jan; 5(1):31-48. PubMed ID: 16370954
[TBL] [Abstract][Full Text] [Related]
13. Il-4 and IFN-gamma mRNA induction in human peripheral lymphocytes specific for beta-lactam antibiotics in immediate or delayed hypersensitivity reactions.
Gaspard I; Guinnepain MT; Laurent J; Bachot N; Kerdine S; Bertoglio J; Pallardy M; Lebrec H
J Clin Immunol; 2000 Mar; 20(2):107-16. PubMed ID: 10821462
[TBL] [Abstract][Full Text] [Related]
14. Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Peña-Mendizabal E; Morais S; Maquieira Á
Sci Rep; 2020 Sep; 10(1):16037. PubMed ID: 32994501
[TBL] [Abstract][Full Text] [Related]
15. β-Lactam hypersensitivity involves expansion of circulating and skin-resident T
Sullivan A; Wang E; Farrell J; Whitaker P; Faulkner L; Peckham D; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2018 Jan; 141(1):235-249.e8. PubMed ID: 28219704
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Antipiperacillin IgG Binding to Structurally Related Drug Protein Adducts.
Amali MO; Jenkins RE; Meng X; Faulkner L; Whitaker P; Peckham D; Park BK; Naisbitt DJ
Chem Res Toxicol; 2017 Dec; 30(12):2097-2099. PubMed ID: 29148816
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and/or cephalosporin antibiotics.
Moss RB; McClelland E; Williams RR; Hilman BC; Rubio T; Adkinson NF
Rev Infect Dis; 1991; 13 Suppl 7():S598-607. PubMed ID: 2068466
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactam hypersensitivity in children with cystic fibrosis: a study in a specialized pediatric center for cystic fibrosis and drug allergy.
Matar R; Le Bourgeois M; Scheinmann P; de Blic J; Ponvert C
Pediatr Allergy Immunol; 2014 Feb; 25(1):88-93. PubMed ID: 24237053
[TBL] [Abstract][Full Text] [Related]
19. Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses.
Koch C; Hjelt K; Pedersen SS; Jensen ET; Jensen T; Lanng S; Valerius NH; Pedersen M; Høiby N
Rev Infect Dis; 1991; 13 Suppl 7():S608-11. PubMed ID: 2068467
[TBL] [Abstract][Full Text] [Related]
20. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.
Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
